Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
22.33
-0.24 (-1.06%)
At close: Jul 19, 2024, 4:00 PM
23.30
+0.97 (4.34%)
Pre-market: Jul 22, 2024, 6:53 AM EDT

Bicycle Therapeutics Revenue

Bicycle Therapeutics had revenue of $41.61M in the twelve months ending March 31, 2024, with 168.47% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $19.53M with 298.90% year-over-year growth. In the year 2023, Bicycle Therapeutics had annual revenue of $26.98M with 86.52% growth.

Revenue (ttm)
$41.61M
Revenue Growth
+168.47%
P/S Ratio
22.88
Revenue / Employee
$146,514
Employees
284
Market Cap
951.99M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.98M12.51M86.52%
Dec 31, 202214.46M2.77M23.65%
Dec 31, 202111.70M1.31M12.58%
Dec 31, 202010.39M-3.41M-24.72%
Dec 31, 201913.80M6.67M93.40%
Dec 31, 20187.14M5.08M246.41%
Dec 31, 20172.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Avanos Medical 680.10M
CareDx 275.11M
BioLife Solutions 137.30M
Tango Therapeutics 37.23M
Silence Therapeutics 33.86M
AnaptysBio 22.96M
Revenue Rankings